© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Innovation Value Initiative
Latest from Innovation Value Initiative
In Evaluating Rheumatoid Arthritis Treatments, Involving Patients Is Key
December 17, 2021
Article
Stacy Courtnay is the community network chair for the Arthritis Foundation in Atlanta highlights a report that discusses how understanding patient experiences in RA can shift questions researchers ask.
CMS Announces "Refresh" of CMMI With Focus on Health Equity, Fewer Models
October 20, 2021
Article
Physician and health policy advocates praised the emphasis on streamlining models and ending silos, but practices that invested in the Oncology Care Model (OCM) await key details.
Redefining Value Assessment to Better Engage Employers, Optimize Health Care Decision-Making
June 03, 2021
Article
Stakeholders discuss barriers and solutions to employer engagement on value assessment, which includes redefining goals to that of the employer and patient, and moving beyond the scope of cost and clinical outcomes.
IVI to Hold Second Methods Summit to Drive Patient-Centered Value Assessment
April 27, 2021
Article
The summit will address priority patient inputs for comparative effectiveness research and health technology assessments.
Contributor: A Vision for Patient-Centered Core Impact Sets—A Unifying Approach to Patient Centricity
March 10, 2021
Article
The authors, from the National Health Council, the EveryLife Foundation for Rare Diseases, and the Innovation and Value Initiative, unveil a project to develop a blueprint for creating patient-centered core impact sets.
Open-Source Modeling Builds Trust, Validity, and Rapid-Cycle Learning in Value Assessment
December 11, 2020
Article
The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — released its latest Value Blueprints research brief describing the benefits and challenges of employing open-source modeling in value assessment
Why Accounting for Our Differences Matter in Assessing Drug Value
June 01, 2020
Article
The authors discuss how more efforts need to ensure the methods used to measure the “value” of new therapies include factors that reflect patient heterogeneity.
Putting Patients First: IVI Launches Patient Advisory Council
May 08, 2020
Article
The Innovation and Value Initiative (IVI), a research-based non-profit improving the science and practice of value assessment, announced the appointment of seven members to its Patient Advisory Council, and advisory body designed to ensure the patient always remains at the forefront of value assessment.
PRESS RELEASE: Dr. Patricia Deverka Appointed as IVI's First Chief Science Officer
February 05, 2020
Article
The Innovation and Value Initiative (IVI) appoints Patricia Deverka, MD, as its first Chief Science Officer.
IVI Research Brief Uses Insurance Value to Determine Long-Term Value of Therapies
July 29, 2019
Article
A research brief from the Innovation and Value Initiative (IVI) looked at how the concept of insurance value can help stakeholders understand the value of therapies to the broader population.
IVI Research Brief Uses Patient Insights as Foundation for Value
May 28, 2019
Article
A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer patients’ perspectives and experiences shape cancer-related treatment decisions.
IVI Research Brief Explores Implications of "Value of Hope"
May 28, 2019
Article
A research brief from the Innovation and Value Initiative (IVI) took a look at how accounting for patients’ attitudes towards risks in treatment outcomes affects value.